Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamid and ATG for allogeneic stem cell transplantation in patients with relapsed or high-risk acute myeloic leukaemia

被引：0
|
作者：
Chemnitz, J. [1 ]
Holtik, U. [1 ]
Theurich, S. [1 ]
Shimabokuro-Vornhagen, A. [1 ]
Hallek, M. [1 ]
Scheid, C. [1 ]
机构：
[1] Stem Cell Transplantat Program Cologne, Cologne, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [41] Combination of fludarabine, amsacrine and cytarabine followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in 60 patients with high-risk acute myeloid leukaemia
    Krejci, M.
    Doubek, M.
    Racil, Z.
    Brychtova, Y.
    Koristek, Z.
    Navratil, M.
    Tomiska, M.
    Horky, O.
    Sandecka, V.
    Dusek, L.
    Mayer, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S393 - S393
  • [42] Allogeneic stem cell transplantation after conditioning FLU-BU12 (± ATG) in patients with acute myeloid leukaemia
    Rusinakova, Z.
    Raida, L.
    Faber, E.
    Vondrakova, J.
    Indrak, K.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S285 - S285
  • [43] Impact of conditioning intensity on outcome in high-risk myelofibrosis undergoing allogeneic stem cell transplantation
    Gagelmann, N.
    Badbaran, A.
    Ditschkowski, M.
    Bogdanov, R.
    Panagiota, V
    Thol, F.
    Robin, M.
    Heuser, M.
    Beelen, D.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 58 - 59
  • [44] Outcomes of patients with high-risk acute myeloid leukaemia relapsed after allogeneic stem cell transplantation. Single-centre experience
    Steinerova, K.
    Koza, V.
    Jindra, P.
    Karas, M.
    Svoboda, T.
    Lysak, D.
    Vokurka, S.
    Vozobulova, V.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S116 - S116
  • [45] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS RECEIVING A FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING (RIC) AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION (allo-HSCT)
    Detrait, M.
    Chevallier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Ducastelle, S.
    Chelghoum, Y.
    Barraco, F.
    Labussiere, H.
    Mohty, M.
    Michallet, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S335 - S336
  • [46] Flamsa Sequential Chemotherapy Followed By Reduced Intensity Conditioning and Allogeneic Hematopoietic Transplantation for High Risk Acute Myeloid Leukemia Patients
    Michallet, Mauricette
    Sobh, Mohamad
    Detrait, Marie Y.
    Labussiere-Wallet, Helene
    Hayette, Sandrine
    Tigaud, Isabelle
    Elhamri, Mohamed
    Gilis, Lila
    Lebras, Laure L.
    Barraco, Fiorenza
    Ducastelle, Sophie
    Bozzoli, Valentina
    Nicolini, Franck E.
    Thomas, Xavier
    BLOOD, 2014, 124 (21)
  • [47] Outcome of High-Risk and Refractory AML/MDS Patients Receiving a FLAMSA Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)
    Detrait, Marie Y.
    Chevallier, Patrice
    Sobh, Mohamad
    Guillaume, Thierry
    Thomas, Xavier
    Morisset, Stephane
    Tedone, Nathalie
    Delaunay, Jacques
    Nicolini, Franck E.
    Labussiere, Helene
    Ducastelle, Sophie
    Fattoum, Jihane
    Barraco, Fiorenza
    Cannas, Giovanna
    Chelghoum, Youcef
    Mohty, Mohamad
    Michallet, Mauricette
    BLOOD, 2011, 118 (21) : 853 - 854
  • [48] Comparison of a fast transplant versus a classical conditioning strategy in allogeneic stem cell transplantation of high-risk acute myeloid leukaemia
    Duenzinger, U.
    Bug, G.
    Martin, H.
    Mousset, S.
    Ajib, S.
    Klein, S.
    Serve, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S271 - S272
  • [49] Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia
    Dominik Schneidawind
    Birgit Federmann
    Christoph Faul
    Wichard Vogel
    Lothar Kanz
    Wolfgang Andreas Bethge
    Annals of Hematology, 2013, 92 : 1389 - 1395
  • [50] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
12345